Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Goodwill (2016 - 2025)

Historic Goodwill for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $5.1 billion.

  • Surgery Partners' Goodwill rose 90485.49% to $5.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year increase of 90485.49%. This contributed to the annual value of $5.1 billion for FY2024, which is 1715.21% up from last year.
  • Per Surgery Partners' latest filing, its Goodwill stood at $5.1 billion for Q3 2025, which was up 90485.49% from $5.1 billion recorded in Q2 2025.
  • In the past 5 years, Surgery Partners' Goodwill registered a high of $5.1 billion during Q1 2025, and its lowest value of $20.0 million during Q2 2021.
  • Over the past 5 years, Surgery Partners' median Goodwill value was $483.0 million (recorded in 2024), while the average stood at $2.0 billion.
  • In the last 5 years, Surgery Partners' Goodwill crashed by 9941.33% in 2021 and then skyrocketed by 654015.54% in 2025.
  • Surgery Partners' Goodwill (Quarter) stood at $3.9 billion in 2021, then rose by 5.76% to $4.1 billion in 2022, then rose by 4.57% to $4.3 billion in 2023, then increased by 17.15% to $5.1 billion in 2024, then rose by 0.47% to $5.1 billion in 2025.
  • Its Goodwill was $5.1 billion in Q3 2025, compared to $5.1 billion in Q2 2025 and $5.1 billion in Q1 2025.